Sexual behaviour and papillomavirus exposure in cervical intraepithelial neoplasia:: a population-based case-control study

被引:65
作者
Kjellberg, L
Wang, ZH
Wiklund, F
Edlund, K
Ångström, T
Lenner, P
Sjöberg, I
Hallmans, G
Wallin, KL
Sapp, M
Schiller, J
Wadell, G
Mählck, CG
Dillner, J
机构
[1] Karolinska Inst, Ctr Microbiol & Tumor Biol, S-17177 Stockholm, Sweden
[2] Univ Hosp No Sweden, Dept Obstet & Gynecol, Umea, Sweden
[3] Univ Hosp No Sweden, Ctr Oncol, Umea, Sweden
[4] Univ Hosp No Sweden, Dept Clin Virol, Umea, Sweden
[5] Univ Hosp No Sweden, Dept Clin Cytol, Umea, Sweden
[6] Univ Hosp No Sweden, Dept Nutr Res, Umea, Sweden
[7] Johannes Gutenberg Univ Mainz, Dept Med Microbiol, D-6500 Mainz, Germany
[8] NCI, Cellular Oncol Lab, Bethesda, MD 20892 USA
[9] Univ Tampere, Sch Publ Hlth, FIN-33101 Tampere, Finland
关键词
D O I
10.1099/0022-1317-80-2-391
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Sexual history is an established risk determinant for cervical neoplasia. It is not clear if human papillomavirus (HPV) exposure entirely explains the sexual behaviour-related risk or if other sexually transmitted agents may act as cofactors for HPV in carcinogenesis. The aim of this study was to elucidate whether HPV exposure or HPV persistence explains the sexual history-related risk of high-grade cervical intraepithelial neoplasia (CIN) using a population-based case-control study of most of the 254 women referred to colposcopy in the Vasterbotten county in Sweden because of an abnormal cervical smear during October 1993 to December 1995 and 320 age-matched women from the general population. The women were interviewed for sexual history and tested for presence of serum antibodies to HPV-16, -18 and -33 as well as for presence of HPV DNA in cervical brush samples. HPV-16, -18 and -33 seropositivity was specific for the corresponding type of HPV DNA, dependent on the lifetime sexual history and associated with a two- to threefold increased risk of CIN 3. There was no sexual history-related risk of CIN among HPV-seropositive women and adjustment for HPV DNA presence explained the sexual history-related risk of GIN. In conclusion, HPV exposure appeared to explain the sexual history-related risk of high-grade CIN.
引用
收藏
页码:391 / 398
页数:8
相关论文
共 43 条
[1]  
af Geijersstam V, 1998, J INFECT DIS, V177, P1710, DOI 10.1086/517428
[2]   Comparison of development of serum antibodies to HPV16 and HPV33 and acquisition of cervical HPV DNA among sexually experienced and virginal young girls - A longitudinal cohort study [J].
AnderssonEllstrom, A ;
Dillner, J ;
Hagmar, B ;
Schiller, J ;
Sapp, M ;
Forssman, L ;
Milsom, I .
SEXUALLY TRANSMITTED DISEASES, 1996, 23 (03) :234-238
[3]   GENITAL HUMAN PAPILLOMAVIRUS INFECTION IN FEMALE UNIVERSITY-STUDENTS AS DETERMINED BY A PCR-BASED METHOD [J].
BAUER, HM ;
TING, Y ;
GREER, CE ;
CHAMBERS, JC ;
TASHIRO, CJ ;
CHIMERA, J ;
REINGOLD, A ;
MANOS, MM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 265 (04) :472-477
[4]  
BECKER TM, 1994, JAMA-J AM MED ASSOC, V271, P1181, DOI 10.1001/jama.271.15.1181
[5]  
BRINTON LA, 1987, J NATL CANCER I, V79, P23
[6]   The natural history of human papillomavirus type 16 capsid antibodies among a cohort of university women [J].
Carter, JJ ;
Koutsky, LA ;
Wipf, GC ;
Christensen, ND ;
Lee, SK ;
Kuypers, J ;
Kiviat, N ;
Galloway, DA .
JOURNAL OF INFECTIOUS DISEASES, 1996, 174 (05) :927-936
[7]  
Chua KL, 1996, INT J CANCER, V68, P54, DOI 10.1002/(SICI)1097-0215(19960927)68:1<54::AID-IJC11>3.0.CO
[8]  
2-6
[9]   Immunoglobulin G responses against human papillomavirus type 16 virus-like particles in a prospective nonintervention cohort study of women with cervical intraepithelial neoplasia [J].
deGruijl, TD ;
Bontkes, HJ ;
Walboomers, JMM ;
Schiller, JT ;
Stukart, MJ ;
Groot, BS ;
Chabaud, MMR ;
Remmink, AJ ;
Verheijen, RHM ;
Helmerhorst, TJM ;
Meijer, CJLM ;
Scheper, RJ .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (09) :630-638
[10]   SEXUALLY-TRANSMITTED AGENTS AND CERVICAL NEOPLASIA IN COLOMBIA AND SPAIN [J].
DESANJOSE, S ;
MUNOZ, N ;
BOSCH, FX ;
REIMANN, K ;
PEDERSEN, NS ;
ORFILA, J ;
ASCUNCE, N ;
GONZALEZ, LC ;
TAFUR, L ;
GILI, M ;
LETTE, I ;
VILADIU, P ;
TORMO, MJ ;
MOREO, P ;
SHAH, K ;
WAHREN, B .
INTERNATIONAL JOURNAL OF CANCER, 1994, 56 (03) :358-363